Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital
28 April 2023, Israel: Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN,
Read More